Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lunan New Time Bio-Tech is a prominent biotechnology subsidiary of the Lunan Pharmaceutical Group, based in Linyi, China. The company specializes in the research, development, and large-scale manufacturing of biopharmaceuticals, including monoclonal antibodies, recombinant proteins, and vaccines. It operates extensive GMP-certified facilities that support both internal pipeline development and contract manufacturing services. Key therapeutic areas of focus include oncology, metabolic diseases, and autoimmune disorders, with several biosimilar and innovative products in various stages of clinical development and commercialization. The company plays a critical role in Lunan Pharma's transition from traditional chemical drugs to high-tech biological therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lunan New Time Bio-Tech.